FindTrial
Sign In

Orange juice and blood Orange juice intake to assess inflammation among tobacco smokers.

Analysis of the inflammatory response and microRNAs expression of smoker patients after orange juice and orange juice with anthocyanins intake

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-97g48p
Enrollment
Unknown
Registered
2019-01-08
Start date
2018-11-06
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Research conducted in adult humans and tobacco smokers. Inflammation, cigarette smoke

Interventions

Orange juice suplementation (400ml): 14 subjects once a week Blood Orange juice suplementation (400ml): 14 subjects once a week Placebo (water - 400ml): 14 subjects once a week Blood withdraw - 5ml a
Dietary supplement
F17.2
F17.1

Sponsors

Universidade Estadual Paulista "Júlio de Mesquita Filho"
Lead Sponsor
Fundação de Amparo à Pesquisa do Estado de São Paulo FAPESP
Collaborator

Eligibility

Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: over 18 years old; both sexes; tobacco smokers

Exclusion criteria

Exclusion criteria: use of nutritional supplements;use of corticosteroids; presence of respiratory diseases; presence of diabetes melittus II, obesity; dyslipidemia; câncer; heart failure; kidney and/or liver diseases.

Design outcomes

Primary

MeasureTime frame
Decrease in the inflammatory markers and microRNAs expression after 3 weeks of suplementation of Orange juice and blood Orange juice—

Secondary

MeasureTime frame
Not expected—

Countries

Brazil

Contacts

Public ContactMariana;Mariana Dorna;Dorna

Universidade Estadual Paulista "Júlio de Mesquita Filho";Universidade Estadual Paulista "Júlio de Mesquita Filho"

mari_dorna@yahoo.com.br;mari_dorna@yahoo.com.br+5514981637856;38801171

Outcome results

None listed

Source: REBEC (via WHO ICTRP)